Skip to content

Clinical trials

Phase 1 Pancreatic Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1 Country / region: China Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20121
20131
20142
20151
20166
20173
20182
20193
20203
20217
202212
202312
202418
202511
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status34
Recruiting31
Not yet recruiting9
Completed8
Terminated6
Active, not recruiting2
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chongqing Precision Biotech Co., Ltd5
Betta Pharmaceuticals Co., Ltd.4
Ruijin Hospital4
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine3
Beijing Protgen Biotechnology Development Co., Ltd.2
Changhai Hospital2
Eli Lilly and Company2
First Affiliated Hospital of Wenzhou Medical University2
Peking Union Medical College Hospital2
Peking University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms92
Colorectal Neoplasms23
Stomach Neoplasms22
Breast Neoplasms12
Lung Neoplasms12
Esophageal Neoplasms11
Ovarian Neoplasms10
Carcinoma, Non-Small-Cell Lung8
Liver Neoplasms7
Neoplasm Metastasis5

Trials

Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.